Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IGEN International -- Ignore unavailable to you. Want to Upgrade?

To: John Zwiener who wrote (278)	3/6/1998 11:20:00 PM
From: James Perry	Read Replies (1) \| Respond to of 1025

Au contrare! Even the expected is not boring when it occurs at this pace. I love it!! And as we see one sign after another, one commences to attach some relevance and significance to a statement someone recited that "they (Igen) want to be the Intel of testing!", and I think maybe there is a bit of perception spreading that this sytem of testing and the devices by which it may be performed (now, and reasonably expectable in the future) is truly capable of leading the market and could become the "brand name" recognized for quality and performance. At that point, one does not measure the value of individual deals, but instead starts to place value upon franchise - the status of the brand, in producing income into the future. And as you point out, the narrow float suggests that the value could be pushed beyond realistic proportions as the company grows and exerts that dominance. Of course, such an opportunity can be blown but that is why waiting is done in a watchful fashion.